Scribd Logo
Upload

Welcome to Scribd!

  • Patient's Initial: R.O. Diagnosis: UTI Date of Exposure: March 9-10, 2015 Area of Exposure: MISC Ward at TLJPH

    Uploaded by

    itsmeaya
    25 views1 page
    R.O. was diagnosed with a UTI after exposure at the MISC Ward of TLJPH on March 9-10, 2015. They were prescribed the antibiotic cefuroxime (brand name Zinnat) intravenously every 8 hours. Cefuroxime is a second-generation cephalosporin antibiotic that works by inhibiting bacterial cell wall synthesis, causing bacterial cell death. It is indicated to treat a variety of bacterial infections including UTIs, skin infections, respiratory infections, and more. Potential adverse reactions include GI issues, rash, increased kidney markers, and allergic reactions. Nursing considerations include monitoring for hypersensitivity, checking culture and sensitivity tests, and monitoring kidney function.

    Original Description:

    drug study

    Original Title

    Cefuroxime

    Copyright

    © © All Rights Reserved

    Available Formats

    DOC, PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Report this Document
    R.O. was diagnosed with a UTI after exposure at the MISC Ward of TLJPH on March 9-10, 2015. They were prescribed the antibiotic cefuroxime (brand name Zinnat) intravenously every 8 hours. Cefuroxime is a second-generation cephalosporin antibiotic that works by inhibiting bacterial cell wall synthesis, causing bacterial cell death. It is indicated to treat a variety of bacterial infections including UTIs, skin infections, respiratory infections, and more. Potential adverse reactions include GI issues, rash, increased kidney markers, and allergic reactions. Nursing considerations include monitoring for hypersensitivity, checking culture and sensitivity tests, and monitoring kidney function.

    Copyright:

    © All Rights Reserved
    Download as DOC, PDF, TXT or read online from Scribd
    Flag for inappropriate content
    Download as doc, pdf, or txt
    25 views1 page

    Patient's Initial: R.O. Diagnosis: UTI Date of Exposure: March 9-10, 2015 Area of Exposure: MISC Ward at TLJPH

    Uploaded by

    itsmeaya
    R.O. was diagnosed with a UTI after exposure at the MISC Ward of TLJPH on March 9-10, 2015. They were prescribed the antibiotic cefuroxime (brand name Zinnat) intravenously every 8 hours. Cefuroxime is a second-generation cephalosporin antibiotic that works by inhibiting bacterial cell wall synthesis, causing bacterial cell death. It is indicated to treat a variety of bacterial infections including UTIs, skin infections, respiratory infections, and more. Potential adverse reactions include GI issues, rash, increased kidney markers, and allergic reactions. Nursing considerations include monitoring for hypersensitivity, checking culture and sensitivity tests, and monitoring kidney function.

    Copyright:

    © All Rights Reserved
    Download as DOC, PDF, TXT or read online from Scribd
    Flag for inappropriate content
    Download as doc, pdf, or txt
    of 1

    Patients Initial: R.O.

    Diagnosis: UTI
    Date of Exposure: March 9-10, 2015
    Area of Exposure: MISC Ward @ TLJPH

    Generic Name
    cefuroxime
    250 g IVTT/q8h

    Brand Name
    Zinnat

    Classification
    Therapeutic:
    Antibiotic
    Pharmacologic:
    Second-generation
    Cephalosporin

    Mechanism of Action
    Inhibits bacterial cell wall
    synthesis. Lack of bacterial
    cell wall results in death of cell
    due to lysis of bacteria.

    Indications

    Bone and
    joint
    infections
    Bronchitis
    Meningitis
    Gonorrhea
    Otitis media
    Pharyngitis/
    Tonsillitis
    Sinusitis
    Lower
    respiratory
    tract
    infections
    Skin and soft
    tissue
    infections
    Urinary tract
    infections
    Surgical
    prophylaxis

    Adverse Reactions
    GI: Diarrhea, nausea,
    antibiotic associated colitis.
    Skin: Rash , pruritus,
    urticaria.

    Nursing Considerations

    Lab tests:

    Urogenital: Increased serum


    creatinine and BUN,
    decreased creatinine
    clearance.
    Hemat: Hemolytic anemia
    MISC: Anaphylaxis

    Perform culture and


    sensitivity tests before
    initiation of therapy and
    periodically during
    therapy if indicated.
    Therapy may be instituted
    pending test results.
    Monitor periodically BUN
    and creatinine clearance.
    During:
    Inspect IM and IV
    injection sites frequently
    for signs of phlebitis.
    Monitor for
    manifestations of
    hypersensitivity

    You might also like